Schellenberg Wittmer advised the Land Degradation Neutrality Fund (LDN Fund), represented by its investment manager Mirova in connection with its USD 9.3m investment in Koa, a Swiss-Ghanaian B Corp-certified company that seeks to add value
Tags :Marcel Jakob
Santhera Pharmaceuticals Holding has announced the grant of an exclusive North America license for the commercialization of vamorolone to Catalyst Pharmaceuticals for a total consideration of up to USD 231 million
The first edition of “Mergers & Acquisitions” co-edited by Florian S. Jörg (partner at Bratschi, pictured left), Urs Gnos (partner at Walder Wyss, pictured center) and Schellenberg Wittmer corporate/m&a partner Lorenzo
Schellenberg Wittmer has advised Avaloq Group on its sale of Avaloq Outline, a global outsourcing provider for business process solutions and innovative document management services, to Swiss Post Solutions. The renowed provider in banking software,
Perfect Holding announced the completion of the reverse takeover transaction (RTO) with Kinarus, a clinical-stage biopharmaceutical company engaged in the discovery and development of novel therapeutics for the treatment of viral, respiratory, and ophthalmic disease.
Kinarus, a privately owned clinical-stage biopharmaceutical company active in the development of novel treatments for patients suffering from serious viral, respiratory and ophthalmic diseases, signed a Transaction Agreement with SIX-listed Perfect Holding regarding Perfect Holding’
Arsenal Capital Partners, a global private equity firm focusing on franchises in the healthcare and industrial sectors, has completes its acquisition of ATP Group from Bregal Unternehmerkapital. Swiss headquartered ATP Group is a manufacturer of
Schellenberg Wittmer advised Credit Suisse on its private banking client referral agreement with Barclays as part of the plan to exit nine wealth management markets primarily in Sub-Saharan Area, excluding South Africa, as announced in
Schellenberg Wittmer advised Santhera Pharmaceuticals regarding an exclusive license agreement for the Greater China Region with Sperogenix Therapeutics, a China-based company specialising in orphan diseases. Under this agreement, Sperogenix will in-license the drug candidate Vamorolone
Carify, a Switzerland based car subscription platform, has successfully completed its equity financing round. Investors in Carify include Zurich Insurance, Toni Piëch as well as ACE & Company. The financing will enable the finalist
